First Trust Advisors
GMAB icon

First Trust Advisors’s Genmab GMAB Stock Holding History

First Trust Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.7M Buy
2,756,522
+295,180
+12% +$7.84M 0.04% 463
2026
Q1 		$66M Buy
2,461,342
+1,126,069
+84% +$33.7M 0.05% 476
2025
Q4 		$41.1M Sell
1,335,273
-352,115
-21% -$11M 0.03% 644
2025
Q3 		$51.8M Sell
1,687,388
-82,922
-5% -$2.02M 0.04% 547
2025
Q2 		$36.6M Buy
1,770,310
+60,504
+4% +$1.24M 0.03% 696
2025
Q1 		$33.5M Buy
1,709,806
+65,518
+4% +$1.37M 0.03% 692
2024
Q4 		$34.3M Buy
1,644,288
+251,241
+18% +$5.52M 0.03% 673
2024
Q3 		$34M Buy
1,393,047
+184,074
+15% +$4.92M 0.03% 626
2024
Q2 		$30.4M Sell
1,208,973
-20,597
-2% -$584K 0.03% 645
2024
Q1 		$36.8M Sell
1,229,570
-40,525
-3% -$1.19M 0.04% 580
2023
Q4 		$40.4M Buy
1,270,095
+175,292
+16% +$5.5M 0.04% 486
2023
Q3 		$38.6M Sell
1,094,803
-99,303
-8% -$3.78M 0.05% 485
2023
Q2 		$45.4M Sell
1,194,106
-80,887
-6% -$3.22M 0.05% 470
2023
Q1 		$48.1M Buy
1,274,993
+79,840
+7% +$3.07M 0.06% 456
2022
Q4 		$50.7M Sell
1,195,153
-96,347
-7% -$3.97M 0.06% 447
2022
Q3 		$41.5M Buy
+1,291,500
New +$45.3M 0.05% 472
2022
Q2 		– Sell
-77,538
Closed -$2.81M – 2535
2022
Q1 		$2.81M Sell
77,538
-66,941
-46% -$2.3M ﹤0.01% 1637
2021
Q4 		$5.72M Sell
144,479
-171,287
-54% -$7.14M 0.01% 1305
2021
Q3 		$13.8M Sell
315,766
-164,722
-34% -$7.39M 0.01% 910
2021
Q2 		$19.6M Buy
+480,488
New +$18.5M 0.02% 788
2021
Q1 		– Sell
-719,688
Closed -$29.3M – 2426
2020
Q4 		$29.3M Buy
719,688
+353,483
+97% +$13.2M 0.04% 518
2020
Q3 		$13.4M Buy
366,205
+228,434
+166% +$8.26M 0.02% 636
2020
Q2 		$4.67M Buy
137,771
+72,131
+110% +$1.97M 0.01% 1009
2020
Q1 		$1.39M Buy
65,640
+29,854
+83% +$665K ﹤0.01% 1460
2019
Q4 		$799K Buy
+35,786
New +$781K ﹤0.01% 1970

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

First Trust Advisors's GMAB Position: Q2 2026 in Review

First Trust Advisors increased its Genmab (GMAB) stake by 12% in Q2 2026, buying an estimated $7.84M and bringing the position to 2,756,522 shares worth $75.7M. The position accounts for 0.04% of the portfolio, ranked #463.

First Trust Advisors first reported a position in GMAB in Q4 2019 and has held it in 25 quarters since. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • First Trust Advisors held 2,756,522 shares of Genmab worth $75.7M as of Q2 2026.
  • First Trust Advisors bought 295,180 Genmab shares in Q2 2026, an estimated $7.84M.
  • Genmab made up 0.04% of First Trust Advisors's portfolio in Q2 2026, its #463 holding.
  • First Trust Advisors first reported a position in Genmab in Q4 2019 and has held it in 25 quarters since.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.